Business Services Industry

Court nod for Mayne demerger.

Australasian Business Intelligence, November, 2005

Nov 20, 2005 (The Australian - ABIX via COMTEX) -- Victoria's Supreme Court has paved the way for Mayne Group to de-merge and begin trading as two separate companies. The court has approved the proposal that will see the company split into two - the international Mayne Pharma pharmaceuticals business and the

domestic health care business, to be known as Symbion Health. Trading in the two companies will begin on 21 November 2005, with Citigroup valuing Symbion shares at $A2.97 each and Mayne Pharma shares at $A2.41 each.

Publication Date: 19 November 2005

 
MAYNE GROUP LIMITED - ASX MAY: 
MAYNE PHARMA LIMITED - ASX MYP: 
SYMBION HEALTH LIMITED: 
SUPREME COURT OF VICTORIA: 
CITIGROUP PTY...
    
            
        		
        
        
    
    	    
                
                
	
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement